Parus Finance (UK)’s BioNTech BNTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-23,817
Closed -$1.91M 33
2024
Q2
$1.91M Buy
23,817
+691
+3% +$63.2K 0.55% 24
2024
Q1
$2.13M Sell
23,126
-2,848
-11% -$273K 0.8% 23
2023
Q4
$2.74M Buy
25,974
+312
+1% +$31.4K 1.42% 16
2023
Q3
$2.79M Sell
25,662
-3,453
-12% -$382K 1.74% 18
2023
Q2
$3.14M Sell
29,115
-1,431
-5% -$161K 1.3% 16
2023
Q1
$3.81M Buy
30,546
+558
+2% +$76.6K 2.28% 14
2022
Q4
$4.5M Sell
29,988
-800
-3% -$123K 3.06% 13
2022
Q3
$4.15M Sell
30,788
-12,165
-28% -$1.86M 3.61% 8
2022
Q2
$6.4M Buy
42,953
+28,613
+200% +$4.37M 3.81% 12
2022
Q1
$2.45M Sell
14,340
-18,414
-56% -$3.09M 0.87% 20
2021
Q4
$8.44M Sell
32,754
-18,116
-36% -$4.96M 2.71% 12
2021
Q3
$13.9M Sell
50,870
-17,336
-25% -$5.51M 4% 7
2021
Q2
$15.3M Buy
68,206
+7,043
+12% +$1.33M 3.7% 8
2021
Q1
$6.68M Buy
61,163
+11,953
+24% +$1.27M 1.83% 19
2020
Q4
$4.01M Buy
+49,210
New +$4.83M 1.17% 23

Other funds holding BNTX

Parus Finance (UK)'s BNTX Position: Q3 2024 in Review

Parus Finance (UK) sold out of BioNTech (BNTX) in Q3 2024, closing a stake of 23,817 shares — an estimated $1.91M sold.

Parus Finance (UK) first reported a position in BNTX in Q4 2020 and held it in 15 quarters. The position peaked at $15.3M in Q2 2021. 296 funds tracked by Wall St. Rank hold BNTX as of Q3 2024.

  • Parus Finance (UK) reported no remaining BioNTech position as of Q3 2024 after selling out during the quarter.
  • Parus Finance (UK) sold 23,817 BioNTech shares in Q3 2024, an estimated $1.91M.
  • Parus Finance (UK) first reported a position in BioNTech in Q4 2020 and held it in 15 quarters.
  • Parus Finance (UK)'s BioNTech position peaked at $15.3M in Q2 2021.
  • 296 funds tracked by Wall St. Rank held BioNTech as of Q3 2024.

Based on Parus Finance (UK)'s 13F filing for Q3 2024, filed 14 Nov 2024.